| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Obesity > Why It Doesn't Pay To Be Overweight |
|
E-Articles - Why It Doesn't Pay To Be Overweight
Being overweight reaches beyond personal appearance and pride. If you are overweight, you are likely to trigger or worsen any number of healt According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product h problems. Obesity is now thought to be as big a cause of ill-health as smoking! I have listed the major health problems associated with be ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ng obese or overweight. Its important to remember that I am not saying you will have these problems. Rather, your chances of having at least lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ne significantly increase the more excess weight you carry.
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe the leading causes of death and disability in the western world. Being overweight increases your chances of angina and sudden death from hea d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro t disease and stroke. Recent research suggests that if your waist size is above 35 inches your risk of heart disease is high.
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ng>High blood pressure High blood pressure rarely makes you feel ill. That is not to say its harmless. It can lead to heart disease easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi Being overweight is one of the causes of high blood pressure.
Noninsulin-dependent diabetes (Type 2 dia nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically etes) is the most common type of diabetes. About 8 in 10 people diagnosed with Type 2 diabetes are overweight. Carrying extra weight may caus and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ the insulin the body produces to work less effectively. This makes diabetes more likely to develop. The effect is more severe if the excess ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi eight is around the waist. One of the most serious long term risks of diabetes is cardiovascular disease.
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a Cancers of the colon, breast (postmenopausal), endometrium (the lining of the uterus), cervix, gall bladder, and ovary are associated with ob dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod sity in women. Overweight men are at greater risk of developing prostate cancer, cancer of the colon, and cancer of the rectum. In 2002, it cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin as estimated that approximately 3% of all new cancers are linked with obesity. A recent study estimated that, in the United States, 14 percen tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen of deaths from cancer in men and 20 percent of deaths in women were due to overweight.
S t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel eep apnea causes a person to stop breathing for short periods during sleep. It can also cause daytime sleepiness. The more overweight you are ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust , the greater the risk of developing sleep apnea.
This joint disorder normally affects joints in y y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ur knees, hips, and lower back. The extra weight increases the risk of osteoarthritis. The excess weight is thought to wear away the protecti . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de e cartilage from the joints. You also increase the risk of the following if you are overweight:
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ssion
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Effective Communications In Our Digital World How Diet Can Relieve IBS Symptoms
|